Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Infant Bacterial Therapeutics AB

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 Equal arrow 0 More Arrow 293
Earnings before taxes -136,905 More Arrow -123,066 More Arrow -65,451
EBITDA -145,343 More Arrow -134,617 More Arrow -65,808
Total assets 239,566 More Arrow 351,334 Less Arrow 349,619
Current assets 230,610 More Arrow 341,563 Less Arrow 339,031
Current liabilities 69,303 Less Arrow 46,180 Less Arrow 17,913
Equity capital 170,263 More Arrow 305,154 More Arrow 331,706
- share capital 3,672 Equal arrow 3,672 Less Arrow 3,060
Employees (average) 10 Less Arrow 8 Less Arrow 7

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 71.1% More Arrow 86.9% More Arrow 94.9%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -57.1% More Arrow -35.0% More Arrow -18.6%
Current ratio 332.8% More Arrow 739.6% More Arrow 1892.7%
Return on equity (ROE) -80.4% More Arrow -40.3% More Arrow -19.7%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 2 Less Arrow 1 Less Arrow -1
Chg. No. of employees % 25% Less Arrow 14% Less Arrow -13%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.